Detalhe da pesquisa
1.
Economic Evaluations of CAR-T Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review.
Value Health
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641057
2.
Building a Platform for Meaningful Patient Partnership to Accelerate "Bench-to-Bedside" Translation of Promising New Therapies.
Healthc Q
; 24(SP): 74-79, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467515
3.
Evaluation of a preoperative personalized risk communication tool: a prospective before-and-after study.
Can J Anaesth
; 67(12): 1749-1760, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929659
4.
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience.
Pharmacoeconomics
; 40(11): 1119-1130, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071263
5.
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
Front Immunol
; 13: 1074740, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601119
6.
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.
Trials
; 22(1): 230, 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766105
7.
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial.
BMJ Open
; 11(3): e043929, 2021 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741670
8.
Stakeholder engagement in economic evaluation: Protocol for using the nominal group technique to elicit patient, healthcare provider, and health system stakeholder input in the development of an early economic evaluation model of chimeric antigen receptor T-cell therapy.
BMJ Open
; 11(8): e046707, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34385243
9.
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trials.
Res Involv Engagem
; 6: 61, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072399